PROPSEA, safety evaluation of palbociclib and ribociclib in older patients with breast cancer: A prospective real-world TOG study

Tarih

Yazarlar

Karaboyun, Kubilay

Sakalar, Teoman

Yayınevi

Anahtar kelimeler

Geriatrics, CDK 4, 6 inhibitors, Breast cancer, Adverse events

URI

https://openaccess.acibadem.edu.tr/handle/11443/6235

Koleksiyonlar

Tam öğe sayfası